Fresenius SE & Co. (OTCMKTS:FSNUY) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Fresenius SE & Co. (OTCMKTS:FSNUY) issued its quarterly earnings results on Wednesday. The company reported $0.24 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.01), Zacks reports. Fresenius SE & Co. had a return on equity of 10.09% and a net margin of 6.55%.

Fresenius SE & Co. Stock Up 5.7%

OTCMKTS FSNUY traded up $0.72 on Wednesday, hitting $13.55. 8,263 shares of the stock were exchanged, compared to its average volume of 152,603. Fresenius SE & Co. has a fifty-two week low of $10.33 and a fifty-two week high of $33.93. The company has a 50-day moving average price of $11.69 and a 200-day moving average price of $12.77. The company has a quick ratio of 0.98, a current ratio of 1.27 and a debt-to-equity ratio of 0.41. The company has a market cap of $30.54 billion, a PE ratio of 18.07 and a beta of 0.61.

Analyst Upgrades and Downgrades

Separately, Morgan Stanley reiterated an “overweight” rating on shares of Fresenius SE & Co. in a research report on Tuesday, July 21st. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Fresenius SE & Co. currently has a consensus rating of “Buy”.

Fresenius SE & Co. Company Profile

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.